CORT
Corcept Therapeutics IncCompany with tickers: CORT
Market Cap
$9.28B
Shares Outstanding
107,351,594
CIK
1088856
CUSIP
218352102
13F Activity (30d)
12 filings
7 filers
Website
Visit website
Investor Relations
Investor relations
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$200,000,000
as of 2024-01-31
Remaining Authorization
$11,400,000
as of 2025-09-30
Program Utilization
94.3%
$188,600,000 used of $200,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-03-31 YTD | $0 | 10-Q, filed 2026-04-30 | ||
| 2025-12-31 | $172,915,000 | 10-K, filed 2026-02-24 | ||
| 2024-12-31 | $15,664,000 | 10-K, filed 2026-02-24 | ||
| 2023-12-31 | $0 | 10-K, filed 2026-02-24 | ||
| 2022-12-31 | $0 | 10-K, filed 2025-02-26 | ||
| 2020-12-31 | $9,945,000 | 10-K, filed 2021-02-23 | ||
| 2019-12-31 | $30,975,000 | 10-K, filed 2021-02-23 | ||
| 2018-12-31 | $23,657,000 | 10-K, filed 2021-02-23 | ||